308 related articles for article (PubMed ID: 26393886)
21. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
[TBL] [Abstract][Full Text] [Related]
22. circDENND4C, a novel serum marker for epithelial ovarian cancer, acts as a tumor suppressor by downregulating miR-200b/c.
Liu S; Yuan L; Li J; Liu Y; Wang H; Ren X
Ann Med; 2023 Dec; 55(1):908-919. PubMed ID: 36896567
[TBL] [Abstract][Full Text] [Related]
23. Utility of Serum miR-125b as a Diagnostic and Prognostic Indicator and Its Alliance with a Panel of Tumor Suppressor Genes in Epithelial Ovarian Cancer.
Zuberi M; Khan I; Mir R; Gandhi G; Ray PC; Saxena A
PLoS One; 2016; 11(4):e0153902. PubMed ID: 27092777
[TBL] [Abstract][Full Text] [Related]
24. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
[TBL] [Abstract][Full Text] [Related]
25. The biphasic expression pattern of miR-200a and E-cadherin in epithelial ovarian cancer and its correlation with clinicopathological features.
Xu S; Xu P; Wu W; Ou Y; Xu J; Zhang G; Li J; Xu G
Curr Pharm Des; 2014; 20(11):1888-95. PubMed ID: 23888941
[TBL] [Abstract][Full Text] [Related]
26. The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer.
Zuberi M; Khan I; Gandhi G; Ray PC; Saxena A
Tumour Biol; 2016 Aug; 37(8):11259-66. PubMed ID: 26951510
[TBL] [Abstract][Full Text] [Related]
27. miR-215 functions as a tumor suppressor in epithelial ovarian cancer through regulation of the X-chromosome-linked inhibitor of apoptosis.
Ge G; Zhang W; Niu L; Yan Y; Ren Y; Zou Y
Oncol Rep; 2016 Mar; 35(3):1816-22. PubMed ID: 26676658
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-130b functions as a tumor suppressor by regulating RUNX3 in epithelial ovarian cancer.
Paudel D; Zhou W; Ouyang Y; Dong S; Huang Q; Giri R; Wang J; Tong X
Gene; 2016 Jul; 586(1):48-55. PubMed ID: 27048832
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of microRNA-203 is associated with advanced tumor progression and poor prognosis in epithelial ovarian cancer.
Wang S; Zhao X; Wang J; Wen Y; Zhang L; Wang D; Chen H; Chen Q; Xiang W
Med Oncol; 2013; 30(3):681. PubMed ID: 23918241
[TBL] [Abstract][Full Text] [Related]
30. miR-335 represents an independent prognostic marker in epithelial ovarian cancer.
Cao J; Cai J; Huang D; Han Q; Chen Y; Yang Q; Yang C; Kuang Y; Li D; Wang Z
Am J Clin Pathol; 2014 Mar; 141(3):437-42. PubMed ID: 24515774
[TBL] [Abstract][Full Text] [Related]
31. Decreased expression of microRNA-148a predicts poor prognosis in ovarian cancer and associates with tumor growth and metastasis.
Gong L; Wang C; Gao Y; Wang J
Biomed Pharmacother; 2016 Oct; 83():58-63. PubMed ID: 27470550
[TBL] [Abstract][Full Text] [Related]
32. Tumor suppressor role of miR-217 in human epithelial ovarian cancer by targeting IGF1R.
Li J; Li D; Zhang W
Oncol Rep; 2016 Mar; 35(3):1671-9. PubMed ID: 26708715
[TBL] [Abstract][Full Text] [Related]
33. The Promising Signatures of Circulating microRNA-145 in Epithelial Ovarian Cancer Patients.
Zuberi M; Mir R; Khan I; Javid J; Guru SA; Bhat M; Sumi MP; Ahmad I; Masroor M; Yadav P; Vishnubhatla S; Saxena A
Microrna; 2020; 9(1):49-57. PubMed ID: 30799804
[TBL] [Abstract][Full Text] [Related]
34. Molecular bases of aberrant miR-182 expression in ovarian cancer.
Marzec-Kotarska B; Cybulski M; Kotarski JC; Ronowicz A; Tarkowski R; Polak G; Antosz H; Piotrowski A; Kotarski J
Genes Chromosomes Cancer; 2016 Nov; 55(11):877-89. PubMed ID: 27295517
[TBL] [Abstract][Full Text] [Related]
35. Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer.
Guo J; Liu C; Wang W; Liu Y; He H; Chen C; Xiang R; Luo Y
PLoS One; 2018; 13(7):e0200716. PubMed ID: 30048472
[TBL] [Abstract][Full Text] [Related]
36. The role of the long non-coding RNA TDRG1 in epithelial ovarian carcinoma tumorigenesis and progression through miR-93/RhoC pathway.
Chen S; Wang LL; Sun KX; Xiu YL; Zong ZH; Chen X; Zhao Y
Mol Carcinog; 2018 Feb; 57(2):225-234. PubMed ID: 28984384
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma.
Fan Y; Fan J; Huang L; Ye M; Huang Z; Wang Y; Li Q; Huang J
Int J Clin Exp Pathol; 2015; 8(4):4132-7. PubMed ID: 26097603
[TBL] [Abstract][Full Text] [Related]
38. miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma.
Zhou S; Wang B; Hu J; Zhou Y; Jiang M; Wu M; Qin L; Yang X
Tumour Biol; 2016 Jul; 37(7):9001-7. PubMed ID: 26758431
[TBL] [Abstract][Full Text] [Related]
39. The role of long non-coding RNA PCA3 in epithelial ovarian carcinoma tumorigenesis and progression.
Liu Y; Zong ZH; Guan X; Wang LL; Zhao Y
Gene; 2017 Oct; 633():42-47. PubMed ID: 28864116
[TBL] [Abstract][Full Text] [Related]
40. Down-regulated miR-22 as predictive biomarkers for prognosis of epithelial ovarian cancer.
Wan WN; Zhang YQ; Wang XM; Liu YJ; Zhang YX; Que YH; Zhao WJ; Li P
Diagn Pathol; 2014 Sep; 9():178. PubMed ID: 25257702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
